Luc Paquet
Directeur Général chez Univalor, Inc.
Profil
Luc Paquet is currently the President, Chief Executive Officer & Director at Univalor, Inc. He is also the Chief Executive Officer at Immune Biosolutions, Inc. Previously, he served as the President & Chief Executive Officer at TransferTech Sherbrooke from 2013 to 2018.
He was also the Secretary & Director at Quantum eMotion, Inc. from 2016 to 2021.
Additionally, he held the position of Director at Institut de Pharmacologie et de Biologie Structurale from 2007 to 2013 and Vice Dean at the University of Sherbrooke from 2010 to 2013.
He briefly served as the Vice President-Business Development at Consortium Québécois sur la Découverte du Médicament in 2013.
Mr. Paquet holds a doctorate degree from the University of Montréal, which he obtained in 1993, and an undergraduate degree from the University of Sherbrooke, which he received in 1987.
Postes actifs de Luc Paquet
| Sociétés | Poste | Début |
|---|---|---|
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Directeur Général | 15/07/2019 |
Immune Biosolutions, Inc.
 Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Directeur Général | 02/11/2021 |
Anciens postes connus de Luc Paquet
| Sociétés | Poste | Fin |
|---|---|---|
| QUANTUM EMOTION CORP. | Directeur/Membre du Conseil | 09/08/2021 |
TransferTech Sherbrooke
 TransferTech Sherbrooke Miscellaneous Commercial ServicesCommercial Services TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada. | Directeur Général | 01/01/2018 |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Corporate Officer/Principal | 01/07/2013 |
| University of Sherbrooke | Corporate Officer/Principal | 01/03/2013 |
| Institut de Pharmacologie et de Biologie Structurale | Directeur/Membre du Conseil | 01/01/2013 |
Formation de Luc Paquet
| University of Sherbrooke | Undergraduate Degree |
| University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUANTUM EMOTION CORP. | Electronic Technology |
| Entreprise privées | 4 |
|---|---|
TransferTech Sherbrooke
TransferTech Sherbrooke Miscellaneous Commercial ServicesCommercial Services TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada. | Commercial Services |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Commercial Services |
Univalor, Inc.
Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Health Technology |
